Quantcast
Channel: MassDevice
Browsing all 12024 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

BrainScope wins FDA nod for Ahead 300 TBI scanner

Brainscope said today that it won FDA 510(k) clearance for its next-gen Ahead 300 traumatic brain injury assessment device, developed through a partnership with the U.S. Defense Dept. The Bethesda,...

View Article


Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for September 26, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article


Image may be NSFW.
Clik here to view.

Hill-Rom picks up Tridien Medical, inks $1.5B term loan, reportedly deals...

Update: Added more information and comments from PeriGen. Hill-Rom (NYSE:HRC) said it paid an undisclosed amount for patient positioning device maker Tridien Medical and took out a $1.45 billion loan,...

View Article

Image may be NSFW.
Clik here to view.

St. Jude seeks shareholder approval for Abbott merger

Updated to correct St. Jude’s headquarters to St. Paul, Minn. from the inappropriately tagged Memphis, Tenn. St. Jude Medical (NYSE:STJ) is reaching out to shareholders to approve its proposed $25...

View Article

Image may be NSFW.
Clik here to view.

California tech councils OCTANe, OC Tech Alliance to merge

Two Southern California technology councils are set to merge, according to a new report from the Orange County Business Journal. Aliso Viejo, Calif.-based OCTANe will merge with Mission Viejo,...

View Article


Image may be NSFW.
Clik here to view.

NovaBone wins CE Mark for collagen-based dental wound dressings

Bio-active synthetic bone graft company NovaBone said today that it won CE Mark approval in the European Union for its NovaTape and NovaPlug dental wound dressings. The Jacksonville, Fla.-based company...

View Article

Image may be NSFW.
Clik here to view.

US issues final rules for clinical trial information reporting

By Stewart Eisenhart, Emergo Group EMERGO SUMMARY OF KEY POINTS: A final rule from the US Department of Health and Human Services (HHS) expands clinical trial reporting requirements to the...

View Article

Image may be NSFW.
Clik here to view.

Gore wins Medicare add-on status for Excluder stent graft

W.L. Gore & Assoc. said today that it won new technology status from the U.S. Centers for Medicare & Medicaid Services for its Gore Excluder iliac branch endoprosthesis. Set to go into effect...

View Article


Image may be NSFW.
Clik here to view.

Boston Scientific to pay $210m for EndoChoice

Boston Scientific (NYSE:BSX) said today that it agreed to pay $210 million for EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease. The $8-per-share offer is slated to...

View Article


Image may be NSFW.
Clik here to view.

Mylan clarifies $104 profit on $600 EpiPens

Mylan (NSDQ:MYL) said again today that it makes just $104 profit on its $600 EpiPen, after the Wall Street Journal reported that the company applied the statutory U.S. tax rate of 37.5% for its...

View Article

Image may be NSFW.
Clik here to view.

Japanese regulators approve Abiomed’s Impella heart pumps

Abiomed (NSDQ:ABMD) said today that it won approval from the Japanese Ministry of Health, Labor & Welfare’s Pharmaceuticals & Medical Devices Agency for its Impella line of heart pumps. The...

View Article

Image may be NSFW.
Clik here to view.

Elekta touts MR-imaging radiotherapy combo at ASTRO

Richard Hausmann built his career on the physics of imaging – he spent 23 years at Siemens (NYSE:SI) and 4 years at GE (NYSE:GE) developing the magnetic resonance and computerized tomography businesses...

View Article

Image may be NSFW.
Clik here to view.

IsoRay settles class action shareholders suit for $3.5m

IsoRay (NYSE:ISR) said it inked a $3.5 million settlement deal related to a class action suit brought against it by shareholders in June. The Richland, Wash.-based company is facing putative...

View Article


Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for September 27, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article

Image may be NSFW.
Clik here to view.

Rotation Medical touts new shoulder repair data

Rotation Medical today released data from a study of its bioinductive implants, designed as part of a novel rotator cuff repair system, touting the device’s ability to promote new connective tissue....

View Article


Image may be NSFW.
Clik here to view.

SentreHeart closes $35m Series D for Lariat trial

SentreHeart said today that it landed a $35 million Series D round from Deerfield Management, with funds slated to support a trial evaluating its Lariat suture delivery system. The Amaze trial aims to...

View Article

Image may be NSFW.
Clik here to view.

A Wireless Medical Device Manufacturer’s Guide to Market Conformity

In today’s SMART and connected world, medical devices are no exception to the world of wireless technologies. In fact, the number of wireless medical devices is growing exponentially. As medical...

View Article


Image may be NSFW.
Clik here to view.

Ximedica tapped to advise Cambridge MedSpace incubator

Ximedica said today it inked a strategic partnership deal with healthcare technology incubator Cambridge MedSpace. Get the rest of the story at our sister site, Medical Design & Outsourcing The...

View Article

Image may be NSFW.
Clik here to view.

Medtronic touts 1st-in-human use of Sugar.IQ with Watson ‘cognitive app’

Medtronic (NYSE:MDT) said today it launched its Sugar.IQ with Watson ‘cognitive app’ for people living with diabetes. The 1st users participating in the testing of the final release candidate will...

View Article

Image may be NSFW.
Clik here to view.

Siemens investors back Kaeser

(Reuters) – Siemens (NYSE:SI) Chief Executive Joe Kaeser has signaled he wants to renew his contract when it runs out in 2018, a move welcomed by investors who have grown to trust the 59-year-old...

View Article
Browsing all 12024 articles
Browse latest View live